Docking Prediction of Amantadine in the Receptor Binding Domain of Spike Protein of SARS-CoV-2,ACS Pharmacology & Translational Science

当前位置： X-MOL 学术 › ACS Pharmacol. Transl. Sci. › 论文详情

Our official English website, www.x-mol.net, welcomes your feedback! (Note: you will need to create a separate account there.)

Docking Prediction of Amantadine in the Receptor Binding Domain of Spike Protein of SARS-CoV-2
ACS Pharmacology & Translational Science ( IF 4.9 ) Pub Date : 2020-11-03 , DOI: 10.1021/acsptsci.0c00172
Abdul Mannan Baig ₁ , Areeba Khaleeq ₁ , Hira Syeda ₂

Affiliation

Amantadine has recently been shown to improve patients with COVID-19. In addition to its known mechanism of actions, we performed docking prediction of this drug on the receptor-binding domain of severe acute respiratory syndrome coronavirus 2, SARS-CoV-2. We hypothesize that such interaction may possibly have contributed a role in the clinical improvements reported.

中文翻译：